Ultralife acquires Electrochem Solutions for $50M; expects EPS accretive in 2025

ULTRALIFE CORP

Purchase price $50M cash; transaction expected to close by end of October 2024.
Electrochem had trailing 12-month revenue of $34M as of June 30, 2024.
Deal expected accretive on EPS basis for 2025; financed via amended credit facilities.
Khristine Carroll to join as SVP-GM of Electrochem upon closing.
Acquisition targets gross margin expansion through vertical integration and synergies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.